Gene Therapy for ACM Due to a PKP2 Pathogenic Variant

Conditions: Arrhythmogenic Cardiomyopathy; PKP2-ACM; PKP2-ARVC Interventions: Genetic: LX2020 Sponsors: Lexeo Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials